Coromandel International Ltd Q2 FY2026 Concall Summary & Transcript Notes

Source transcript PDF: https://www.stockscans.in/document/esro7nylrmcsl9qug3od01du.pdf

# 1. Financial Performance

## A. Key Figures
   *   **Crop Protection Revenue:** **₹829 Cr** (+10%) · **EBIT:** **₹162 Cr** (+48%)
   *   **Consolidated Total Income:** **₹9,771 Cr** Q2 (+30%) · **₹16,897 Cr** H1 (+38%) (incl. ₹245 Cr NACL)
   *   **Consolidated EBITDA:** **₹1,147 Cr** Q2 (+18%) · **₹1,929 Cr** H1 (+30%)
   *   **PAT:** **₹793 Cr** Q2 (+20%) · **₹1,295 Cr** H1 (+34%)
   *   **Subsidy Receipts:** **₹3,336 Cr** Q2 · **₹4,637 Cr** H1 (vs. ₹3,855 Cr prior-year H1) · **Outstanding: ₹3,199 Cr** (vs. ₹1,714 Cr)

## B. Revenue Growth
   *   **Strong Segment Momentum:** Crop protection delivered robust top-line and **significant EBIT expansion**, reflecting pricing power and operating leverage.
   *   **Consolidation Impact:** NACL added ₹245 Cr in H1 income, though contribution was limited to **50 days of operations**, creating a timing mismatch in expense recognition.

## C. Profitability Trends
   *   **Margin Resilience:** Consolidated EBITDA growth outpaced revenue, driven by **operational efficiency** and **strong offtake**, despite **one-off costs** from NACL integration.
   *   **Mancozeb as Growth Engine:** **Exceptional profitability** in Mancozeb was the primary driver behind the **PBIT margin uplift from 15% to 20%**.
   *   **Cost Pressures:** Higher other expenses due to **shift in CSR recognition** and **one-time consultancy charges** related to NACL transaction.

## D. Subsidy Impact
   *   **Stable Subsidy Dependency:** Subsidy-linked revenue remained **consistently high at ~83%**, with **70–71% of EBITDA** derived from this stream, underscoring structural reliance.
   *   **Favorable Policy Timing:** **10% hike in Phosphorus subsidy** for Rabi season provides pricing support and demand visibility.
   *   **Working Capital Pressure:** Subsidy outstandings rose significantly, with **₹1,000 Cr attributed to delayed government disbursements**, but expected to normalize post-season.

## E. Cash Flow Position
   *   **Non-Recurring Costs:** Other expenses rose **30–50% YoY** due to **quarterly CSR spend shift** and **one-time charges**, including a **₹25 Cr accounting adjustment** to align NACL’s policies with Coromandel.

---

# 2. Product & Segment Performance

## A. Key Figures
   *   **SSP Volumes:** +6% H1 YoY (flat Q2)
   *   **Specialty Nutrients Revenue Growth:** +20% QoQ
   *   **Formulation Business Growth:** +20% H1 YoY (+11% recently)
   *   **Export Business Growth:** +6% QoQ (Mancozeb up 7–12% H1)
   *   **NACL H1 Revenue:** ₹900 Cr (+18%) · **EBITDA:** ₹83 Cr (+12%)
   *   **Nano Fertilizer Sales:** 1,100 KL (quarterly volume)
   *   **Retail Store Expansion:** 170 stores in H1 (100 in Q2)

## B. Crop Protection Sales
   *   **Market Recovery Underway:** Crop protection offtake rebounding post Kharif disruption, with normalized inventories and strong Rabi season expectations.
   *   **Value-Driven SSP Strategy:** Strategic pivot to value-added SSP variants (Groplus, Gro Alpha) now represent **~50% of total SSP volume**, enhancing DAP substitution in key crops.
   *   **Acquisition Integration on Track:** NACL acquisition delivering against KPIs with **18% revenue growth**, minimal product overlap, and a clear margin improvement roadmap from **4% to 9–11%**.
   *   **Margin Expansion & Innovation:** Standalone CPC EBIT margin expanded to **20%** on portfolio enrichment; new export molecules (Boscalid, Pyraoxystrobin) in registration pipeline.
   *   **Global & Domestic Growth Push:** Ambitious plans for global API markets and Latin America B2C rollout; domestic formulations targeting **25% annual growth** in a **₹29,000 Cr industry** with low current penetration.

## C. Specialty Nutrients & Bio
   *   **High-Growth Specialty Segment:** Specialty nutrients delivered **20% quarterly growth**, driven by sulfur-based and granulated products, including **seaweed granulation**.
   *   **Bio Portfolio Expansion:** Launched **8 new bio-fertilizers/pesticides** and entered strategic API manufacturing collaboration with a global partner.

## D. Retail Segment Expansion
   *   **Aggressive Retail Scaling:** Retail network expanding at **one store per day**, on track for **1,200 stores by FY26** and targeting **2,000 long-term**, with new entries in Maharashtra and Tamil Nadu.
   *   **Branded Formulation Powerhouse:** Combined B2C formulation revenue from Coromandel and NACL projected to reach **₹2,000–2,200 Cr**, reinforcing branded value in farmer engagement.
   *   **Digital & Product Integration:** AI and analytics enhancing retail efficiency; e-commerce, financial services, and insurance to be scaled alongside core offerings.

## E. Nano Fertilizer Adoption
   *   **Nano DAP Gaining Traction:** Nano fertilizer sales at **1,100 KL** in the quarter with strong adoption in horticulture; **Nano DAP volume nearly doubled in H1** despite packaging transition challenges.
   *   **Farmer-Centric Adoption Model:** Nationwide education programs and **ICAR collaborations** driving awareness and positioning Nano as a domestic alternative to imported DAP.
   *   **Future-Ready Product Shift:** Industry moving toward high-efficiency fertilizers (zincated NPKs, slow-release); Coromandel at the forefront with nano and granulation innovation.

---

# 3. Volume & Market Share

## A. Key Figures
   *   **NPK Share of Phosphatic Consumption:** **64%** (up from 50-50 split)
   *   **Market Share (H1):** **19%** consumption-based (up from 17%)
   *   **Sales Volume (Q2):** **+7% YoY** · **H1 Volume:** **+17% YoY**
   *   **Drone Spraying Coverage:** **80,000 acres** (H1, +264% YoY from 22,000)
   *   **Dealer Inventory:** **6–7 lakh tons** (manufactured + imported)

## B. NPK Market Penetration
   *   **Structural Shift to Balanced Nutrition:** NPK’s dominance in phosphatic consumption reflects a **sticky, structural shift** driven by farmer adoption and industry-led extension efforts, reducing reliance on DAP.
   *   **Market Leadership Achieved:** Company is now **India’s largest phosphatic fertilizer marketer**, with gains driven by NPK outperformance and strategic positioning in balanced nutrition.
   *   **Pricing Discipline Maintained:** No notable NPK price hikes in Q2, as adjustments remain **tied to monthly subsidy flows and cost dynamics**.

## C. Regional Sales Growth
   *   **Northern Markets Expansion:** Strong uptake of NP/NPK in **Uttar Pradesh, Rajasthan, and Madhya Pradesh**, where volumes **doubled to 200,000 tons** (H1), with a path to **1 million tons** post-capacity expansion.
   *   **Agri-Services Scale-Up:** Drone spraying services scaled rapidly, covering **80,000 acres** in H1—highlighting growing integration of precision farming with fertilizer sales.

## D. Phosphatic Consumption
   *   **Robust Volume Momentum:** Solid **double-digit H1 volume growth** (+17%) underscores strong demand and distribution execution, despite flat overall phosphatic consumption.

---

# 4. Manufacturing & Capacity

## A. Key Figures
   * NPK Production: 9.1 lakh tons in quarter (+3%)
   *   **Half-Year Phosphoric Acid Output:** **5 lakh tons** (+5%)

## B. Plant Utilization & Operational Performance
   *   **Peak Efficiency:** Q2 marked peak operational performance with **over 100% capacity utilization**, strong phosphatic output, and optimized conversion costs.
   *   **Volume Momentum:** Mancozeb demand drove **full utilization at Sarigam** and prompted **new capacity commissioning at Dahej**, while NPK growth was slightly constrained by **ammonia supply disruptions**.
   *   **Debottlenecking Gains:** Phos acid production saw strong growth from incremental improvements, signaling effective asset optimization ahead of major expansions.

## C. Acid Production Ramp-up
   *   **Near-Term Commissioning:** Mechanical completion of the Kakinada Phos Acid plant expected in **December**, with **trial runs in January** and **commercial production by mid-January**.
   *   **Full Utilization Target:** Management expects **100% capacity utilization** for both phosphoric and sulfuric acid plants by **FY '27**, consistent with historical ramp-up speed.
   *   **Cost Advantage Locked In:** Sulfuric acid investments in Vizag have recovered **60–70% of costs**, with full payback expected this year, delivering **structural EBITDA upside** independent of sulfur price volatility.

## D. CAPEX Projects Progress
   *   **Major Expansion On Track:** **1 million ton NPK capacity addition** at Kakinada progressing on schedule for **Q3 next year** completion.
   *   **Integrated Project Economics:** **$250–$300/ton margin** and **2-year payback** reflect the full value of integration across phosphatic and acid operations.
   *   **Modular Investment Approach:** TMAP expansion to begin with **25,000-ton phase** (CAPEX: **₹150–170 Cr**), enabling scalable, de-risked capital deployment.

## E. Backward Integration
   *   **Final Stage Achieved:** **90% of Kakinada acid integration project** complete, with mechanical completion next quarter and **commissioning targeted for January**.

---

# 5. Supply Chain & Input Costs

## A. Key Figures
   *   **Phosphoric Acid Price:** **$1,290/ton** (up from $1,258)
   *   **Ammonia Price:** **$400–450/ton**
   *   **GST Rates:** Reduced to **5%** for key agri-inputs and fertilizer inputs (from 12% and 18%)

## B. Rock Phosphate Sourcing
   *   **Vertical Integration Accelerates:** Investment in a **MAP plant in Vizag** reduces dependence on Chinese imports and strengthens self-reliance in specialty nutrients.
   *   **Internalization of Supply Chain:** Margin resilience supported by **in-house rock production in Senegal**, advanced processing of low-grade rock, and strategic blending capabilities.
   *   **Diversified Global Sourcing:** New supply opportunities from **Egypt and Jordan** are helping normalize rock availability and pricing.

## C. Raw Material Pricing
   *   **Favorable Tax Regime:** GST reductions across critical inputs alleviate cost pressures and reduce input tax credit pile-up in the fertilizer sector.
   *   **Near-Term Volatility, Medium-Term Relief:** Spikes in **sulfur and ammonia** due to Middle East outages are expected to ease, with **DAP and rock prices softening** amid improved global supply.
   *   **Pricing Divergence Observed:** Rising phosphoric acid costs are not fully reflected in rock prices, creating potential margin expansion opportunities.
   *   **Input Cost Outlook:** Interlinked sulfuric acid, rock, and DAP price stability supports projected returns on new investments.

## D. Import Dependency
   *   **Proactive Government Collaboration:** Industry-led coordination in Q2 ensured robust DAP imports and sufficient inventory build-up ahead of the Rabi season.

## E. Long-term Supply Agreements
   *   **Strategic Offtake Security:** Secured long-term contracts with **Maaden (Saudi Arabia) for DAP** and **Jordan for rock phosphate**, de-risking key input supply.
   *   **Downstream Integration Pipeline:** Future capex to focus on **active ingredient capacity** and **Mancozeb downstream projects**, extending fertilizer-chain synergies into crop protection.

---

# 6. Risks & Agri-Input Factors

## A. Key Figures
   *   **Monsoon Rainfall:** **108%** of LPA (above normal)
   *   **Kharif Acreage Change:** **+1%** YoY (mixed crop impact)
   * Half-Year Industry Consumption: 121 lakh tons (supported by DAP imports)
   * INR/USD Volatility Range: 85.18 to 88.93 (first half)

## B. Weather Disruptions
   *   **Crop Damage from Unseasonal Rains:** Excess rainfall in August–September disrupted crop input applications and damaged standing crops, weighing on consumption momentum.
   *   **Resilient Aggregate Demand:** Despite weather headwinds, industry consumption remained healthy due to **sharp DAP import growth**, with Nano DAP emerging as a key innovation requiring responsible farmer education.

## C. Input Cost Volatility
   *   **Production Resilience:** Sustained DAP and NPK output maintained despite geopolitical supply challenges, supported by a conservative FX hedging strategy amid significant rupee volatility.

## D. GST Credit Uncertainty
   *   **Pending Clarity on Refunds:** Industry continues to await resolution on accumulated GST credit refunds, though recent rate reductions have reduced the pace of credit build-up.

## E. Competitive Intensity
   *   **Defensive Posture on NPK Margins:** Industry evaluating options to protect NPK profitability post-NBS policy, though no specific price actions disclosed.
   *   **Differentiated Farmer Engagement:** Competitive intensity expected to rise; Coromandel’s deployment of agronomists for product education remains a unique differentiator.

---

# 7. Guidance & Outlook

## A. Key Figures
   *   **Northeast Monsoon Rainfall:** **112%** of LPA forecasted for key regions
   *   **Reservoir Levels:** **123%** of LPA in South India (+4% YoY, +16% vs normal)
   *   **MSP Hike:** **4% to 10%** increase for Rabi crops
   *   **Pulses Mission Outlay:** **INR 11,000 Cr** targeting 5 crore tons by 2031 (from 3 crore)
   *   **Phosphoric Acid Project Timeline:** **~6 months** expected

## B. Rabi Season Prospects
   *   **Favorable Agri-Conditions:** Strong monsoon start and record-high reservoir levels signal robust Rabi sowing potential across South India.
   *   **Supportive Policy Environment:** MSP hikes of 4–10% enhance farmer income expectations, underpinning demand for agricultural inputs.
   *   **Operational Confidence:** Industry outlook remains positive with stable input costs, subsidies, and raw material access ensuring fertilizer availability.

## C. Growth Projections
   *   **Pulses Mission as Growth Catalyst:** INR 11,000 Cr national initiative aims for **67% production increase** by 2031, creating scalable downstream opportunities.
   *   **Defense Order Pipeline:** Initial order critical for follow-on momentum; execution timeline remains unspecified.

## D. Synergy Realization
   *   **Strategic Integration Over Cost-Cutting:** NACL-Coromandel merger focused on innovation and R&D convergence, targeting multiplicative growth ("1+1=3").
   *   **Synergy Buildout to Be Phased:** Full realization will take time, with priority on eliminating redundant chemistry efforts and aligning product pipelines.
   *   **Enablers for Transformation:** Success hinges on **pricing freedom, innovation speed, and accelerated government approvals**, all actively pursued.